Thomas Hartman is Vice President of GMP Operations, Biopharm CMC, for GlaxoSmithKline, with responsibility for the clinical supply chain including raw materials, manufacturing operations, engineering, validation, quality control and compliance functions. Tom joined GSK in 2001 in the capacity of Director, Biopharmaceutical Facilities and Systems with responsibilities for Engineering, IT Systems, and Validation for both the US & UK Biopharm GMP and process development facilities. Following his appointment to Director Manufacturing Operations in 2004, he led a major compliance renovation and startup of the GSK’s Biopharmaceutical clinical manufacturing facility in King of Prussia, PA. He was named VP GMP Operations in 2006. Prior to joining GSK, Tom held senior positions in the US and Europe in the specialty chemicals industry including responsibility for engineering, operations, production, and maintenance systems to support manufacturing of raw materials and process intermediates for use in the food and drug industry, and commodity chemical businesses. He was elected to the ISPE Board of Directors in 2013 and serves as an industry advisor to the Delaware Valley Chapter, participates in the Chapter’s annual Owners Advisory Forum and sponsors Chapter educational events. Mr. Hartman earned a BME from Villanova University and an MBA from Eastern University and has been a Member of ISPE for 15 years.